What the Iran War Means for Pharma Supply Chains
Argon & Co’s Michel Savini discusses the medicines most exposed to geopolitical instability, and why scenario planning remains underused across life sciences
False
Argon & Co’s Michel Savini discusses the medicines most exposed to geopolitical instability, and why scenario planning remains underused across life sciences
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
October 2, 2026
1 min read
Ahead of CPHI Milan’s Sustainability Summit, Silvia Forroova and Rob Williams discuss how shared standards and supplier partnerships can turn commitments into measurable progress.
October 2, 2026
5 min read
We asked the 2026 Power List how the pharmaceutical industry can prepare for geopolitical, economic, regulatory, and scientific uncertainty
September 21, 2026
5 min read
From isotope supply to reimbursement, the practical challenges shaping real-world delivery in oncology
August 4, 2026
4 min read
A recent multimillion-dollar freezer failure highlights the urgent need for real-time visibility across the pharmaceutical supply chain
False
Affiliations:
Specialties:
Areas of Expertise: